Breaking: FDA authorizes Paxlovid, a pill, for preventing severe disease in COVID patients 12 & older who are at high risk due to comorbidities or advanced age. I welcome this.
In trials, this drug reduced risk of deaths or hospitalization by almost 90%
washingtonpost.com/health/2021/12…
In trials, this drug reduced risk of deaths or hospitalization by almost 90%
washingtonpost.com/health/2021/12…
Treatment should start as soon as possible after onset of symptoms and within 5 days of symptom onset.
The trial studied adults 18 and older with a prespecified risk factor for progression to severe disease OR were 60 years and older.
The trial studied adults 18 and older with a prespecified risk factor for progression to severe disease OR were 60 years and older.
Link to the FDA authorization. fda.gov/news-events/pr…
Clearly they took some discretion with expanding beyond the phase 3 to include patients 12-18 with risk factors, although the specified a minimum weight. Good decision.
Also shows how much discretionary power they have. And they should be more liberal like this with approving rapid tests. @michaelmina_lab
• • •
Missing some Tweet in this thread? You can try to
force a refresh
